|
|
|
| Viral Vector Upstream Platforms | Optimizing the upstream portion of gene therapy production sets the stage for successful manufacturing by maximizing viral vector titers. To increase upstream titers and process productivity, manufacturers must partner with upstream technology experts who work with HEK293, HEK293T, and Sf9 cells. Draw on our experience today to speed your gene therapy to patients. Learn more here. |
|
|
|
|
By Booma Yandava, M.S., MBA, Principal at Alliance Partners | This author explains why incorporating innovative technologies, such as CRISPR/Cas9, and understanding the molecular basis of neurological disorders are crucial in shaping the future of gene therapy. |
|
|
|
|
| Achieve Fast And Efficient Isolation Of Exosomes From Stem Cells | Application Note | By Pascal Rowart, Vincent Dufey, Jan Knop, and Françoise De Longueville, Eppendorf SE | Review the demonstration of how a bioreactor and bioreactor systems combination is used to isolate exosomes after culturing human adiposederived stem cells in suspension on microcarriers. |
|
|
|
| Enhancing Immunophenotyping Standardization In Clinical Labs | Poster | By Zachary S. Clauss, Martina de Geus, and Kanwal Palla, Slingshot Biosciences, Inc. | Discover how quantitative BCMA or CD19 cell mimics can be used to enhance immunophenotyping practices, providing a versatile and customizable tool for immunophenotyping applications. |
|
|
|
| Increasing mRNA Capabilities And Capacity For A Growing Market | Article | By Sebastian Almeida, Lloyd Jeffs, John Harmer, and Katarina Stenklo, Cytiva | The growing mRNA vaccine market ― projected to reach $127.3 billion by 2027 ― is fueling high demand for mRNA, which has resulted in a critical need to address mRNA manufacturing bottlenecks. |
|
|
|
|
| Uniting supply chain and clinical operations experts, the 5th Supply Chain & Logistics for Cell Therapies Summit gives a unique opportunity to collaborate with the cross-functional roles supporting supply chain management to ensure team alignment. Gain insights that empower you to create a cost-effective, efficient, and patient-centered supply chain and enable you to stretch budgets further, seamlessly onboard patients, and deliver treatments faster. Learn more |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
